The use of FK506 in simultaneous pancreas/kidney transplantation: rescue, induction, and maintenance immunosuppression

Transplant Proc. 1995 Dec;27(6):3123-4.
No abstract available

Publication types

  • Clinical Trial

MeSH terms

  • Blood Glucose / metabolism
  • C-Peptide / blood
  • Creatinine / blood
  • Cyclosporine / adverse effects
  • Diabetes Mellitus, Type 1 / complications
  • Diabetes Mellitus, Type 1 / surgery
  • Diabetic Nephropathies / complications
  • Diabetic Nephropathies / surgery
  • Glycated Hemoglobin / metabolism
  • Graft Rejection / drug therapy
  • Graft Rejection / prevention & control
  • Humans
  • Immunosuppression Therapy / methods
  • Immunosuppressive Agents / adverse effects
  • Immunosuppressive Agents / therapeutic use*
  • Kidney Transplantation* / adverse effects
  • Kidney Transplantation* / physiology
  • Pancreas Transplantation* / adverse effects
  • Pancreas Transplantation* / physiology
  • Tacrolimus / adverse effects
  • Tacrolimus / therapeutic use*

Substances

  • Blood Glucose
  • C-Peptide
  • Glycated Hemoglobin A
  • Immunosuppressive Agents
  • Cyclosporine
  • Creatinine
  • Tacrolimus